feed,title,long_url,short_url
InsiderMonkey,Intellia Reports Positive 3-Year Lonvo-z Data in HAE Trial at EAACI Congress,https://insidermonkey.com/blog/--1555744,
InsiderMonkey,Twist and Element Biosciences Expands Pact for Sequencing Workflow Solutions,https://insidermonkey.com/blog/--1555745,
InsiderMonkey,Lilly To Acquire Verve For One-Time Cardiovascular Treatments,https://insidermonkey.com/blog/--1555746,
InsiderMonkey,10x Genomics Settles Patent Dispute With Bruker,https://insidermonkey.com/blog/--1555747,
InsiderMonkey,Lake Street: AMT-130 Could Be Game-Changer For ClearPoint,https://insidermonkey.com/blog/--1555748,
InsiderMonkey,"Exact Sciences Expands Oncodetect Validation, Unveils MRD Innovation Roadmap",https://insidermonkey.com/blog/--1555749,
InsiderMonkey,First Patient Dosed In Phase 3 REVEAL Study Of ION582 For Angelman Syndrome,https://insidermonkey.com/blog/--1555750,
InsiderMonkey,Barclays Initiates BioMarin Pharmaceutical Inc. (BMRN) with a Buy Rating,https://insidermonkey.com/blog/--1555752,
InsiderMonkey,Biogen Launches Phase 3 Pediatric Trial Of Omaveloxolone For Friedreich Ataxia,https://insidermonkey.com/blog/--1555751,
InsiderMonkey,"Canaccord Raises Price Target Of Illumina, Inc. (ILMN).",https://insidermonkey.com/blog/--1555753,
InsiderMonkey,"UBS Lowers Price Target On Regeneron Pharmaceuticals, Inc. (REGN).",https://insidermonkey.com/blog/--1555754,
